Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Study to Assess the Prognostic Significances of NCCN-IPI and Post-treatment PET Results in Patients With Newly Diagnosed Nodal PTCL

NCT03040206 is registered in ClinicalTrials.gov with Chonbuk National University Hospital as lead sponsor.

NCT NCT03040206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03040206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Study to Assess the Prognostic Significances of NCCN-IPI and Post-treatment PET Results in Patients With Newly Diagnosed Nodal PTCL
Lead sponsor
Chonbuk National University Hospital
Phase
Observational
Overall status
Completed
Start date
January 31, 2017
Completion date
December 31, 2017
Enrollment
405 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anaplastic large cell lymphoma, alk-negative, angioimmunoblastic t-cell lymphoma, peripheral t-cell lymphoma, not otherwise specified